| Mylan Pharma GmbH - Influvac, Injektionssuspension | | 00485 | | 25 | | Influvac | | Injektionssuspension | | J07BB02 | | Influenza, Inactivated, Split Virus Or Surface Antigen | | 11.09.2012 | | |
| | Composition | | haemagglutininum influenzae A (H1N1) 15 µg et neuraminidasum inactivatum (Virus strain A/California/7/2009 (H1N1)-like: Reassortant virus NYMC X-181), haemagglutininum influenzae A (H3N2) 15 µg et neuraminidasum inactivatum (Virus strain A/Victoria/361/2011 (H3N2)-like: Reassortant virus IVR-165), haemagglutininum influenzae B 15 µg et neuraminidasum inactivatum (Virus strain B/Wisconsin/1/2010-like: Reassortant NYMC BX-39 derived from B/Hubei-Wujiagang/158/2009), kalii chloridum, kalii dihydrogenophosphas, dinatrii phosphas dihydricus, natrii chloridum, calcii chloridum dihydricum, magnesii chloridum hexahydricum, residues: ovalbuminum max. 0.1 µg, saccharum et formaldehydum et cetrimidum et polysorbatum 80 et gentamicinum nihil, aqua ad iniectabilia q.s. to suspension for 0.5 ml. | | Packungsbestandteile | | Injection suspension | | | |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| No entries have been found. |
|
|
